Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults–update 2004
D Armstrong, JK Marshall, N Chiba… - Canadian Journal of …, 2005 - Wiley Online Library
BACKGROUND: Gastroesophageal reflux disease (GERD) is the most prevalent acid‐
related disorder in Canada and is associated with significant impairment of health‐related …
related disorder in Canada and is associated with significant impairment of health‐related …
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
There has been no published indepth systematic evaluation of the best approaches to
symptom evaluation in gastro-oesophageal reflux disease (GORD). A two day international …
symptom evaluation in gastro-oesophageal reflux disease (GORD). A two day international …
The burden of selected digestive diseases in the United States
RS Sandler, JE Everhart, M Donowitz, E Adams… - Gastroenterology, 2002 - Elsevier
BACKGROUND & AIMS: Gastrointestinal (GI) and liver diseases inflict a heavy economic
burden. Although the burden is considerable, current and accessible information on the …
burden. Although the burden is considerable, current and accessible information on the …
Functional dyspepsia: the economic impact to patients
BE Lacy, KT Weiser, AT Kennedy… - Alimentary …, 2013 - Wiley Online Library
Background Although highly prevalent, little is known about the economic impact of
functional dyspepsia (FD). Aims To quantify FD patients' health care utilisation patterns and …
functional dyspepsia (FD). Aims To quantify FD patients' health care utilisation patterns and …
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms
DA Revicki, AM Rentz, D Dubois, P Kahrilas… - Quality of Life …, 2004 - Springer
Background: Patient-rated symptom assessments are needed for evaluating the
effectiveness of medical treatments and for monitoring outcomes in gastroparesis. Objective …
effectiveness of medical treatments and for monitoring outcomes in gastroparesis. Objective …
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study
M Camilleri, D Dubois, B Coulie, M Jones… - Clinical …, 2005 - Elsevier
Background & Aims: This study examined the prevalence of upper gastrointestinal (GI)
symptoms and symptom groupings and determined impact on disability days in a nationally …
symptoms and symptom groupings and determined impact on disability days in a nationally …
Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index
DA Revicki, AM Rentz, D Dubois… - Alimentary …, 2003 - Wiley Online Library
Background: Patient‐based symptom assessments are necessary to evaluate the
effectiveness of medical treatments for gastroparesis. Aim: To summarize the development …
effectiveness of medical treatments for gastroparesis. Aim: To summarize the development …
Burden of gastrointestinal symptoms in the United States: results of a nationally representative survey of over 71,000 Americans
CV Almario, ML Ballal, WD Chey… - Official journal of the …, 2018 - journals.lww.com
OBJECTIVES: Digestive diseases account for> 100 million ambulatory care visits annually in
the US Yet, comparatively less is known about the true burden of gastrointestinal (GI) …
the US Yet, comparatively less is known about the true burden of gastrointestinal (GI) …
The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life
C Farup, L Kleinman, S Sloan, D Ganoczy… - Archives of Internal …, 2001 - jamanetwork.com
Background Two types of reflux episodes have been identified: upright or daytime and
supine or nocturnal. The population-based prevalence of symptoms of nocturnal …
supine or nocturnal. The population-based prevalence of symptoms of nocturnal …
Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial
Background & Aims: Gastroesophageal reflux disease is a prevalent disorder that often
requires long-term medical therapy or surgery. The United States Food and Drug …
requires long-term medical therapy or surgery. The United States Food and Drug …